Lysodren is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Hra Pharma Rare Diseases. The primary component is Mitotane.
Product ID | 76336-080_73a3f0f8-bc4e-4b27-bcb8-2fb4873652f6 |
NDC | 76336-080 |
Product Type | Human Prescription Drug |
Proprietary Name | Lysodren |
Generic Name | Mitotane |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2009-01-06 |
Marketing Category | NDA / NDA |
Application Number | NDA016885 |
Labeler Name | HRA Pharma Rare Diseases |
Substance Name | MITOTANE |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Cytochrome P450 3A4 Inducers [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2009-01-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA016885 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-01-06 |
Ingredient | Strength |
---|---|
MITOTANE | 500 mg/1 |
SPL SET ID: | f0cd76e9-460c-450e-b094-172e636f340a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0015-3080 | LYSODREN | MITOTANE |
76336-080 | Lysodren | mitotane |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LYSODREN 73358100 1243390 Live/Registered |
Bristol-Myers Company 1982-04-05 |
LYSODREN 73156066 1099245 Live/Registered |
CALBIOCHEM-BEHRING CORP. 1978-01-23 |